The use of cell saver system in cardiac surgery with cardiopulmonary bypass
The use of cell saver system in cardiac surgery with cardiopulmonary bypass
复制标题
DOI：
10.5935/1678-9741.20130012
复制
发表时间：
2013-03-01
影响因子：
1.3
通讯作者：
Leitão, Luciano
中科院分区：
文献类型：
--
作者：
Almeida, Rui M. S.;Leitão, Luciano
前言：为减少心脏手术中红细胞储存单位(URBC)的使用，增加发病率、死亡率和引起炎症反应，建议在心脏手术中使用CS。目的：评价CS的使用是否减少了URBC的使用，是否具有成本效益和对患者有益。方法：在一项前瞻性研究中，自2009年11月至2011年10月，连续100例心血管手术患者接受体外循环血液稀释和血液滤过。将患者分为1组(非CS组)和2组(CS组)。更换RBC的标准是血流动力学不稳定和血红蛋白(Hb)
Introduction: The use of cell saver (CS) in cardiac surgery is proposed to reduce the use of units of packed red blood cells stored (URBC), which increases morbidity, mortality and causes inflammatory reactions.Objective: The objective is to evaluate whether the use of CS decreases the use URBC, is cost / effective and beneficial to the patient.Methods: In a prospective study, between November 2009 and October 2011, 100 consecutive patients who underwent cardiovascular surgery with CPB, hemodilution and hemofiltration, were enrolled. Patients were divided into group 1 (no CS) and 2 (CS). The criteria for the replacement of RBC were hemodynamic instability and hemoglobin (Hb)